SOURCE: United Treatment Centers, Inc.

September 06, 2011 09:00 ET

United Treatment Centers, Inc. Enters Into Letter of Intent to Acquire Nature's Instincts, Inc.

NEW YORK, NY--(Marketwire - Sep 6, 2011) - United Treatment Centers, Inc. (PINKSHEETS: UTRM) announced today that the company has entered into a Letter of Intent to acquire Houston-based Nature's Instincts, Inc.

Pending the completion of full due diligence by both entities, the transaction is anticipated to be completed during the last half of September 2011.

Mr. Richard M. Johnson, CEO of Nature's Instincts, Inc., stated, "This is an ideal merger for both parties. This will allow both companies to facilitate their business plans and allowed for a unified front making both units stronger than they were before the merger."

Mr. Frank Ottaviani, CEO of United Treatment Centers Inc., said, "We look forward to completing this merger and creating a stronger entity upon closing. The proven track record of Nature's Instincts Stemulite product line and the newly improved Stemulite II will only enhance United Treatment Center's footprint on the retail market."

About Nature's Instincts, Inc.
Nature's Instincts has acquired a proprietary patent-pending platform of all natural health products based on a core technology derived from stem cell research. The products are comprised of a series of natural plant extracts and other natural components with a wide array of properties, all of which benefit from their unique abilities to better integrate the product's advantages into human cell structure and work on the body's own stem cells. Natures Instincts, Inc. offers a total of seven products. They are Stemulite II AM for men, Stemulite II PM for men, Stemulite II AM for women, Stemulite II PM for women, ProStem II, SominaPM and AlertNRG. Nature's Instincts' platform of products are all-natural and have no known negative side effects and are non-addictive. For more information visit:

"Safe Harbor" Statement: Certain statements in this release are "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the Company's ability to meet the terms and conditions required to obtain its project financing, risks and delays associated with product development, risk of market acceptance of new products, risk of technology or product obsolescence, competitive risks, reliance on development partners and the need for additional capital.

Contact Information